SAM
MIRM icon

Smartleaf Asset Management’s Mirum Pharmaceuticals MIRM Stock Holding History

Smartleaf Asset Management’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.9K Hold
89
– – ﹤0.01% 2323
2026
Q1 		$7.82K Hold
89
– – ﹤0.01% 2447
2025
Q4 		$7.02K Buy
89
+72
+424% +$5.17K ﹤0.01% 2549
2025
Q3 		$1.24K Buy
+17
New +$1.08K ﹤0.01% 2709
2025
Q2 		– Sell
-17
Closed -$781 – 2880
2025
Q1 		$781 Hold
17
– – ﹤0.01% 2627
2024
Q4 		$700 Buy
+17
New +$708 ﹤0.01% 2730

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Smartleaf Asset Management's MIRM Position: Q2 2026 in Review

Smartleaf Asset Management held its Mirum Pharmaceuticals (MIRM) position steady in Q2 2026 at 89 shares worth $10.9K. The position accounts for ﹤0.01% of the portfolio, ranked #2323.

Smartleaf Asset Management first reported a position in MIRM in Q4 2024 and has held it in 6 quarters since. 327 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

  • Smartleaf Asset Management held 89 shares of Mirum Pharmaceuticals worth $10.9K as of Q2 2026.
  • Smartleaf Asset Management left its Mirum Pharmaceuticals share count unchanged in Q2 2026.
  • Mirum Pharmaceuticals made up ﹤0.01% of Smartleaf Asset Management's portfolio in Q2 2026, its #2323 holding.
  • Smartleaf Asset Management first reported a position in Mirum Pharmaceuticals in Q4 2024 and has held it in 6 quarters since.
  • 327 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on Smartleaf Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.